European Commission approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of people with extensive-stage small cell lung cancer

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy